Bexovid is a combipack of Nirmatrelvir and Ritonavir tablets. Bexovid is used to treat mild-to-moderate COVID-19 in adults and children (12 years of age and older weighing at least 40 kg).
Bexovid works in our body:
Bexovid® is a combination of Nirmatrelvir and a low dose of ritonavir. Nirmatrelvir disrupts the replication of SARS-CoV-2 in the body by binding to the 3CL-like protease, an enzyme crucial to the virus’ function and reproduction. Ritonavir inhibits the CYP3A-mediated metabolism of Nirmatrelvir, resulting in increased plasma concentrations of Nirmatrelvir.
Indication of Bexovid:
Bexovid® is indicated for mild-to-moderate COVID-19 positive adult and pediatric patients (12 years of age and older weighing at least 40 kg), who are at high risk for progression to severe COVID-19, including hospitalization or death.
Dosage & administration of Bexovid:
Bexovid consists of 2 medicines: nirmatrelvir and ritonavir.
Contraindications of Bexovid:
Adverse effects of Bexovid:
Adverse events (incidence ≥1% and ≥5 subject difference) were dysgeusia, diarrhea, hypertension, and myalgia.
What if one is pregnant or breastfeeding?
There is no experience treating pregnant women or breastfeeding mothers with Bexovid. For a mother and unborn baby, the benefit of taking Bexovid may be greater than the risk from the treatment. If someone is pregnant, discuss the specific situation with healthcare provider.
If someone is breastfeeding, discuss the options and specific situation with healthcare provider.
Storage condition of Bexovid:
Do not store above 30° C. Keep in a dry place. Protect from light and keep out of the reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.